IMPAACT P1115: Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof of Concept Study

Official Title: IMPAACT P1115: Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof of Concept Study

IMPAACT P1115 will explore the effects of early intensive antiretroviral therapy (ART) on achieving HIV remission (HIV RNA below the limit of detection of the assay) among HIV-infected infants.

ClinicalTrials.gov ID: NCT02140255

Principal Investigator: Chadwick, Ellen G., MD

Study Type: Interventional

Currently Recruiting Patients: Yes

Contact Information:

Margaret Ann Sanders

Research and Education Coordinator

312-227-8275

Specialties & Conditions

Patients & Visitors

Plan Your Visit

While You're Here

After Your Visit

IMPAACT P1115: Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof of Concept Study

Official Title: IMPAACT P1115: Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof of Concept Study

Contact Information:

Find

Get in Touch

Get to Know Us

For Healthcare Professionals